Moderna Inc (MRNA)
Solvency ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.33 | 1.35 | 1.74 | 2.86 | 1.35 |
Moderna Inc's solvency ratios indicate the company's ability to meet its long-term financial obligations. Looking at the debt-to-assets ratio, which calculates the proportion of total assets financed by debt, Moderna has maintained a relatively low level of debt compared to its assets over the past five years, ranging from 0.02 to 0.04. This suggests the company is managing its debt well and has a strong asset base.
The debt-to-capital ratio, measuring the proportion of debt relative to the total capital structure, has also been stable, varying between 0.03 to 0.05. This indicates that Moderna's capital structure is not overly reliant on debt financing, which can be seen as a positive sign for investors and creditors.
Furthermore, the debt-to-equity ratio, showing the relationship between debt and shareholders' equity, has been consistent at around 0.03 to 0.06 during the period. This suggests that Moderna has maintained a healthy balance between debt and equity financing, which is crucial for long-term financial stability.
The financial leverage ratio, which indicates the extent to which a company is using debt to fund its operations, shows some fluctuations over the years. However, the ratio has generally been at manageable levels, with the exception of a spike in 2020. This could be a point of concern as a higher leverage ratio indicates a higher reliance on debt to finance operations.
Overall, based on the solvency ratios analyzed, Moderna Inc appears to have a strong financial position with prudent debt management practices in place, although the fluctuations in the financial leverage ratio warrant closer monitoring to ensure the company's long-term financial health.
Coverage ratios
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Interest coverage | -111.55 | 324.83 | 782.12 | -77.14 | -83.27 |
To calculate Moderna Inc's interest coverage ratio, we need data on operating income and interest expense from the financial statements. Unfortunately, the provided table lacks the necessary information to compute the interest coverage ratio for Moderna Inc for the years ending December 31, 2019 to December 31, 2023. Therefore, without access to the specific values of operating income and interest expenses for these periods, a comprehensive analysis of Moderna Inc's interest coverage ratio cannot be conducted.